Astera Labs (NASDAQ:ALAB) Stock Price Target Lowered at TD Cowen

Key Points

• TD Cowen cut its Astera Labs price target from $300 to $225 and maintained a Hold rating; the new target implies just 2.1% upside from the prior close.
• Analyst opinions remain mixed, but the consensus rating is Moderate Buy with an average price target of $318. Susquehanna also lowered its target, while UBS maintained Neutral.
• Astera Labs beat quarterly estimates, reporting EPS of $1.32 versus $1.19 expected and revenue of $584.9 million, up 153.6% year over year. Shares fell $13.26 to $220.36 on Wednesday.

Astera Labs (NASDAQ:ALAB - Get Free Report) had its price target decreased by stock analysts at TD Cowen from $300.00 to $225.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a "hold" rating on the stock. TD Cowen's price target would indicate a potential upside of 2.10% from the company's previous close.

A number of other analysts have also commented on the stock. UBS Group reissued a "neutral" rating and issued a $290.00 price objective on shares of Astera Labs in a research report on Wednesday. Susquehanna decreased their target price on shares of Astera Labs from $310.00 to $258.00 and set a "neutral" rating for the company in a research report on Wednesday. Weiss Ratings lowered shares of Astera Labs from a "buy (b-)" rating to a "hold (c)" rating in a research note on Friday, October 23rd. Royal Bank Of Canada cut their price target on shares of Astera Labs from $500.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday. Finally, Jefferies Financial Group boosted their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $318.00.

Astera Labs Stock Performance

NASDAQ ALAB traded down $13.26 on Wednesday, reaching $220.36. The company had a trading volume of 5,600,957 shares, compared to its average volume of 5,099,883. The firm has a market capitalization of $38.23 billion, a price-to-earnings ratio of 109.42 and a beta of 3.85. The company's fifty day moving average is $306.13 and its 200-day moving average is $255.53. Astera Labs has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs's revenue for the quarter was up 153.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.49 EPS. On average, research analysts forecast that Astera Labs will post 2.71 earnings per share for the current year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company's stock, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 408,558 shares of company stock worth $127,306,034. Insiders own 10.40% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs during the second quarter valued at about $25,000. Archer Investment Corp bought a new stake in shares of Astera Labs during the second quarter worth about $30,000. Transamerica Financial Advisors LLC acquired a new position in shares of Astera Labs in the second quarter valued at approximately $35,000. Continuum Advisory LLC acquired a new position in shares of Astera Labs in the second quarter valued at approximately $37,000. Finally, GK Wealth Management LLC acquired a new position in shares of Astera Labs in the third quarter valued at approximately $29,000. Institutional investors own 60.47% of the company's stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 revenue reached a record $584.9 million, up 154% year over year, and adjusted earnings of $1.32 per share topped estimates of $1.19. Scorpio fabric switches were the largest product family, and management forecast Q4 revenue of $730 million to $750 million. Astera Labs Q3 results
• Positive Sentiment: Northland upgraded ALAB to outperform, while Morgan Stanley raised its price target to $389 and maintained an overweight rating—signs that some analysts see substantial upside. Northland recommendation
• Positive Sentiment: Astera is expanding beyond Scorpio into optical connectivity, memory and rack-scale AI systems, which could provide additional growth drivers over time. Q3 call highlights
• Neutral Sentiment: Analyst views were mixed: RBC cut its target to $400 but kept an outperform rating, while Seeking Alpha upgraded its rating to Hold, citing strong execution but a still-expensive valuation. Seeking Alpha analysis
• Negative Sentiment: Susquehanna lowered its target to $258 and retained a neutral rating. Concerns include ALAB’s valuation, reliance on a few customers and competition from Marvell’s push into optical connectivity—factors that may help explain why the shares fell despite the earnings beat. Barron's coverage

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.